BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211112T130000
DTEND;TZID=Europe/Stockholm:20211112T143000
DTSTAMP:20260405T152847
CREATED:20211029T062301Z
LAST-MODIFIED:20211029T062304Z
UID:59143-1636722000-1636727400@www.scilifelab.se
SUMMARY:Open webinar: How can SciLifeLab\, MAX IV and ESS contribute to drug discovery and development?
DESCRIPTION:During this seminar the three large-scale research infrastructures – SciLifeLab\, MAX IV and ESS – will present their offer to the Life Science industry in form of advanced technologies in the shape of research infrastructure\, as well as relevant data support and structures. Together they can provide technologies ranging from genomics\, proteomics\, genome engineering and drug discovery\, to X-ray beamlines and the most powerful neutron source worldwide. \n\n\n\nThe webinar is a joint venture between Lif and InfraLife\, the initiative that serve as a hubconnecting stakeholders\, displaying the potential of the advanced technologies\, and making these unprecedented tools accessible to be utilized in addressing complex research questions.Who should attend? \n\n\n\nEveryone who works within pharma industry and the Life Science-ecosystem in Sweden and iscurious about what services these three major national infrastructures can offer and how to starta research project. \n\n\n\nRegistration\n\n\n\nPreliminary program: \n\n\n\nWelcomeFrida Lundmark\, Lif \n\n\n\nThe InfraLife projectElin Jonsson and Josefin Lundgren Gawell\, project coordinators InfraLife \n\n\n\nSciLifeLab – possibilities in drug discovery & DevelopmentPer Arvidsson\, Director Drug Discovery & Development platform\, SciLifeLab \n\n\n\nCryo-EM recent development and great possibilities for drug researchMarta Carroni\, Platform Director\, Cell and Molecular Imaging\, SciLifeLab \n\n\n\nThe MAX IV synchrotron and possibilities for Life ScienceSelma Maric\, Industrial Relations\, Life Science and Soft Matter\, MAX IV \n\n\n\nNeutron research possibilities for drug development and the European Spallation Source (ESS)Zoë Fisher\, Group Leader for Deuteration and Macromolecular Crystallisation\, ESS \n\n\n\nIndustry examples from X-ray and neutron experimentsEmanuel Larsson\, Postdoctoral fellow\, Solid Mechanics\, Expert Lunarc (Centre for Scientific and Technological Computing)\, Lund University \n\n\n\nTime for questions \n\n\n\nWrap up and future perspectives
URL:https://www.scilifelab.se/event/open-webinar-how-can-scilifelab-max-iv-and-ess-contribute-to-drug-discovery-and-development/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2020/05/AdobeStock_297709311-scaled.jpeg
ORGANIZER;CN="InfraLife":MAILTO:events@scilifelab.se
END:VEVENT
END:VCALENDAR